New Results
A standardised framework to identify optimal animal models for efficacy assessment in drug development
View ORCID ProfileGuilherme S. Ferreira (PhD Candidate), View ORCID ProfileDésirée Veening-Griffioen (PhD Candidate), Wouter Boon (Assistant Professor), Ellen Moors (Professor), Christine Gispen-de Wied (Scientific Staff), Huub Schellekens (Professor), Peter van Meer (Postdoctoral Researcher Non-Clinical Assessor)
doi: https://doi.org/10.1101/382366
Guilherme S. Ferreira (PhD Candidate)
1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Désirée Veening-Griffioen (PhD Candidate)
1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Wouter Boon (Assistant Professor)
2Copernicus Institute of Sustainable Development, Innovation Studies, Utrecht University, Utrecht, The Netherlands
Ellen Moors (Professor)
2Copernicus Institute of Sustainable Development, Innovation Studies, Utrecht University, Utrecht, The Netherlands
Christine Gispen-de Wied (Scientific Staff)
3Medicines Evaluation Board, Utrecht, The Netherlands
Huub Schellekens (Professor)
1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Peter van Meer (Postdoctoral Researcher Non-Clinical Assessor)
1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
3Medicines Evaluation Board, Utrecht, The Netherlands
Article usage
Posted August 01, 2018.
A standardised framework to identify optimal animal models for efficacy assessment in drug development
Guilherme S. Ferreira (PhD Candidate), Désirée Veening-Griffioen (PhD Candidate), Wouter Boon (Assistant Professor), Ellen Moors (Professor), Christine Gispen-de Wied (Scientific Staff), Huub Schellekens (Professor), Peter van Meer (Postdoctoral Researcher Non-Clinical Assessor)
bioRxiv 382366; doi: https://doi.org/10.1101/382366
A standardised framework to identify optimal animal models for efficacy assessment in drug development
Guilherme S. Ferreira (PhD Candidate), Désirée Veening-Griffioen (PhD Candidate), Wouter Boon (Assistant Professor), Ellen Moors (Professor), Christine Gispen-de Wied (Scientific Staff), Huub Schellekens (Professor), Peter van Meer (Postdoctoral Researcher Non-Clinical Assessor)
bioRxiv 382366; doi: https://doi.org/10.1101/382366
Subject Area
Subject Areas
- Biochemistry (13714)
- Bioengineering (10449)
- Bioinformatics (33189)
- Biophysics (17124)
- Cancer Biology (14193)
- Cell Biology (20129)
- Clinical Trials (138)
- Developmental Biology (10869)
- Ecology (16029)
- Epidemiology (2067)
- Evolutionary Biology (20351)
- Genetics (13401)
- Genomics (18637)
- Immunology (13767)
- Microbiology (32177)
- Molecular Biology (13395)
- Neuroscience (70110)
- Paleontology (527)
- Pathology (2194)
- Pharmacology and Toxicology (3745)
- Physiology (5874)
- Plant Biology (12024)
- Synthetic Biology (3368)
- Systems Biology (8170)
- Zoology (1842)